Chapin Davis Inc. Purchases 45 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Chapin Davis Inc. increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,701 shares of the healthcare conglomerate’s stock after purchasing an additional 45 shares during the period. Chapin Davis Inc.’s holdings in UnitedHealth Group were worth $866,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Signature Resources Capital Management LLC lifted its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares in the last quarter. Legend Financial Advisors Inc. lifted its stake in UnitedHealth Group by 27.4% during the fourth quarter. Legend Financial Advisors Inc. now owns 93 shares of the healthcare conglomerate’s stock worth $49,000 after purchasing an additional 20 shares in the last quarter. Veracity Capital LLC lifted its stake in UnitedHealth Group by 1.5% during the first quarter. Veracity Capital LLC now owns 1,335 shares of the healthcare conglomerate’s stock worth $660,000 after purchasing an additional 20 shares in the last quarter. Rodgers Brothers Inc. raised its stake in shares of UnitedHealth Group by 2.4% in the first quarter. Rodgers Brothers Inc. now owns 842 shares of the healthcare conglomerate’s stock valued at $417,000 after acquiring an additional 20 shares in the last quarter. Finally, Aprio Wealth Management LLC raised its stake in shares of UnitedHealth Group by 2.1% in the second quarter. Aprio Wealth Management LLC now owns 975 shares of the healthcare conglomerate’s stock valued at $497,000 after acquiring an additional 20 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Argus increased their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays increased their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 23rd. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.93 during midday trading on Friday, reaching $577.68. 2,728,939 shares of the company were exchanged, compared to its average volume of 4,224,914. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $591.54. The stock has a fifty day simple moving average of $529.38 and a 200 day simple moving average of $507.42. The stock has a market cap of $533.44 billion, a P/E ratio of 35.31, a PEG ratio of 1.61 and a beta of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $6.14 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.